Many marketed approved drugs harbor unrecognized anti-metastatic potential that remains undiscovered. For instance, multiple cardiovascular medications have been validated to exert potent anti-metastasis effects.

Leveraging our mature cell-based screening platforms, we provide customized drug repurposing services to rapidly screen, verify and pinpoint candidate compounds with promising anti-metastatic activity for your research and development.